The 1315 Capital investment team combines financial and business development expertise with deep industry knowledge to support the growth of our portfolio companies.
1315 Capital employs a unique Operating Team model to navigate diligence, drive decisions, and achieve premium exits.
1315 Capital has a deep network that it leverages for management talent, advisors, deal sourcing, diligence, and boards roles.
May 18, 2018
May 01, 2018
April 26, 2018
Cost containment focused company providing hospitals liquidation alternatives for capital equipment.
Special needs equipment and supply company that serves the pediatric and adult special needs population.
Cosmeceutical company providing natural, mineral-based approach to skin protection and skin health.
Dermatology company committed to delivering innovative prescription therapies and medical devices to dermatologists.
Oncology diagnostics company that provides oncologists and pathologists with comprehensive testing solutions in hematology and solid tumor molecular profiling.
Cost-containment service company focused on reprocessing single-use medical devices.
Specialty pharmaceutical company focused on nutraceutical and women’s health products.
Medical device company focused on the orthopedic oncology market.
Medical technology company providing advanced wound care products to patients with chronic wounds.